Timothy Sullivan

2021

In 2021, Timothy Sullivan earned a total compensation of $3.1M as Chief Financial Officer at Apellis Pharmaceuticals, a 12% decrease compared to previous year.

Compensation breakdown

Bonus$163,800
Option Awards$1,940,625
Salary$452,692
Stock Awards$505,125
Other$13,674
Total$3,075,916

Sullivan received $1.9M in option awards, accounting for 63% of the total pay in 2021.

Sullivan also received $163.8K in bonus, $452.7K in salary, $505.1K in stock awards and $13.7K in other compensation.

Rankings

In 2021, Timothy Sullivan's compensation ranked 4,328th out of 12,415 executives tracked by ExecPay. In other words, Sullivan earned more than 65.1% of executives.

ClassificationRankingPercentile
All
4,328
out of 12,415
65th
Division
Manufacturing
1,783
out of 5,508
68th
Major group
Chemicals And Allied Products
750
out of 2,378
69th
Industry group
Drugs
670
out of 2,099
68th
Industry
Pharmaceutical Preparations
476
out of 1,549
69th

Pay ratio

Timothy Sullivan's Pay$3,075,916
Median Employee's Pay$321,867
Pay Ratio

10

to 1

In 2021, the annual total compensation of Timothy Sullivan was $3,075,916.

The annual total compensation of the median employee at Apellis Pharmaceuticals was $321,867.

The ratio of Timothy Sullivan's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 20, 2022.

Sullivan's colleagues

We found four more compensation records of executives who worked with Timothy Sullivan at Apellis Pharmaceuticals in 2021.

2021

Cedric Francois

Apellis Pharmaceuticals

Chief Executive Officer

2021

Pascal Deschatelets

Apellis Pharmaceuticals

Chief Scientific Officer

2021

Adam Townsend

Apellis Pharmaceuticals

Chief Commercial Officer

2021

Federico Grossi

Apellis Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like